InfuSystem Holdings, Inc.
INFU · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.44 | 0.06 | -100.87 | -2.68 |
| FCF Yield | 1.46% | 0.05% | 1.36% | 0.48% |
| EV / EBITDA | 10.37 | 15.50 | 14.50 | 22.37 |
| Quality | ||||
| ROIC | 3.72% | 2.21% | 0.27% | 3.32% |
| Gross Margin | 52.20% | 50.17% | 55.10% | 57.17% |
| Cash Conversion Ratio | 8.72 | 12.87 | 973.17 | 12.90 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.06% | 7.10% | 4.12% | 8.07% |
| Free Cash Flow Growth | 2,377.36% | -95.66% | 47.05% | -50.68% |
| Safety | ||||
| Net Debt / EBITDA | 1.39 | 2.10 | 2.47 | 2.12 |
| Interest Coverage | 3.88 | 1.88 | 1.18 | 2.05 |
| Efficiency | ||||
| Inventory Turnover | 9.87 | 9.79 | 10.24 | 11.13 |
| Cash Conversion Cycle | 38.46 | 48.18 | 29.99 | 22.26 |